CombiMatrix launches Combimatrix Molecular Diagnostics
CombiMatrix Corporation announced that its subsidiary, Combimatrix Molecular Diagnostics, has completed the clinical validation of its highest density constitutional array genetic test to date, the BAC HD Scan test. Following the successful validation, CombiMatrix has launched the test, which can diagnose over 125 genetic disorders.
-
HairDX launches genetic test for women’s hair loss
Pathway Diagnostics launches SensiTrop II assay
Asuragen Initiates Launch of CE-Marked Molecular Diagnostic Products
Abbott Gets FDA Clearance For Molecular Diagnostic Test For Detection Of Chlamydia And Gonorrhea Infections
Eisai, Sanko Junyaku launch pneumonia test kits
